Asia-Pacific Colorectal Cancer Market to 2028

Asia-Pacific Colorectal Cancer Market to 2028 - Regional Analysis and Forecasts by Modality (Diagnosis Type, Therapy Type, Imaging Type); End User (Hospitals, Diagnostic and Research Laboratories), and Country

Report Code : TIPRE00009518 | Region : Asia Pacific | Industry : Pharmaceuticals | Published Date : 27/Sep/2022

The colorectal cancer market in Asia Pacific is expected to grow from US$ 3,864.66 million in 2022 to US$ 5,169.04 million by 2028; it is estimated to grow at a CAGR of 3.7% from 2022 to 2028.

The growing pharmaceutical industry in emerging economies is creating lucrative opportunities for significant players to expand their businesses in the Asia Pacific colorectal cancer market. The pharmaceutical sector in India is expected to grow from US$ 42 billion in 2021 to US$ 55 billion by 2025; it is estimated to register at a CAGR of 37% from 2021 to 2025. According to India Brand Equity Foundation (IBEF) statistics in April 2019, India is the largest provider of generic drugs worldwide. The Indian pharmaceutical industry supplies ~40% of the generic demand in the US, with ~50% of the demand for multiple vaccines and 25% of all medicines in the UK. Moreover, India has a massive number of scientists and engineers with the potential to grow the healthcare industry remarkably.

Major colorectal cancer market players focus on emerging markets such as Singapore and China as they have many colorectal cancer patients, along with growing medical tourism. As per the Australian Institute of Health and Welfare, over ~15,540 new cases of colorectal cancer were diagnosed in 2021. Moreover, as per the Malaysia Healthcare Travel Council, in 2019, over 1.22 million travelers visited Malaysia for healthcare purposes. The low cost of treatment and incorporation of advanced technologies to provide less waiting time for procedures in Asia Pacific are likely to boost the number of surgeries associated with colorectal cancer. This ultimately increases the demand for colorectal cancer diagnostics and treatment.

Thus, the increasing medical tourism and the growing pharmaceutical industry in emerging countries are expected to boost the APAC colorectal cancer market growth; it is also anticipated to provide significant growth opportunities to the players operating in the market during the forecast period.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Asia Pacific colorectal cancer market. The Asia Pacific colorectal cancer market is expected to grow at a substantial CAGR during the forecast period.

Asia Pacific Colorectal Cancer Market Revenue and Forecast to 2028 (US$ Million)

Asia Pacific Colorectal Cancer Market Segmentation

The Asia Pacific colorectal cancer market is segmented into modality, end user, and country. Based on modality, the Asia Pacific colorectal cancer market is segmented into diagnosis type, therapy type, and imaging type. In 2022, the diagnosis type segment held the largest market share and is expected to register the highest CAGR during the forecast period. Based on end user, the Asia Pacific colorectal cancer market is bifurcated into hospitals and diagnostic & research laboratories. In 2022, the hospitals segment held a larger market share. Based on country, the Asia Pacific colorectal cancer market is segmented into Australia, China, India, Japan, South Korea, and the Rest of Asia Pacific. China held the largest market share in 2022.

Abbott, Amgen Inc., Bruker Corporation, Clinical Genomics Technologies Pty Ltd., EDP Biotech Corporation, Epigenomics AG, F. Hoffmann-La Roche AG, Quest Diagnostics, and VolitionRx Limited are among the leading companies in the Asia Pacific colorectal cancer market.

At 3.7% CAGR, the Asia Pacific Colorectal Cancer Market is speculated to be worth US$ 5,169.04 Million by 2028, says The Insight Partners

According to The Insight Partners’ research, the Asia Pacific colorectal cancer market was valued at US$ 4,627.82 million in 2022 and is expected to reach US$ 5,169.04 million by 2028, registering an annual growth rate of 3.7% from 2022 to 2028. Various benefits offered by generic drugs and growing pharmaceutical industry in emerging economies are the critical factors attributed to the market expansion.

Generic drugs are alternatives to branded drugs. The pharmacological effects of generic drugs are similar to their branded counterparts. Generic drugs are cost-effective as the manufacturers do not invest in developing and marketing a new drug. After the expiry of a drug patent, other manufacturers apply for FDA approval of a generic intended for its manufacturing and selling. Thus, generic drugs are cheaper than their branded counterparts. Generic drugs have the same dosage, effects and side effects, route of administration, risks, safety, and strength as the original branded drugs.

Generic drugs are important in oncology because some anticancer drugs are only offered as generics. Patients are likely to abandon branded prescriptions associated with their higher price. Generic drugs for cancer treatment are profitable for manufacturers and patients due to their affordability and efficacy, especially in developing countries such as India, where paying capacity is relatively low. One of the unique benefits of using generic drugs is that the cost is up to 85%, which is less than branded drugs.

On the contrary, pricing pressure on drug manufacturers hurdles the growth of Asia Pacific colorectal cancer market.

The Asia Pacific colorectal cancer market, based on modality, has been segmented into diagnosis type, therapy type, and imaging type. The therapy type segment held the largest share of the market of 37.0% market share in 2022, amassing US$ 1,428.11 million. It is projected to garner US$ 1,925.41 million by 2028 to expand at 3.8% CAGR during 2022–2028.

By the end user, the Asia Pacific colorectal cancer market is bifurcated into hospitals and diagnostic & research laboratories. With 55.8% share of the domain, the hospitals segment dominated the market in 2022. It accrued US$ 2,157.95 million in 2022 and is estimated to generate US$ 2,975.54 million by 2028 to grow at a CAGR of 4.1% over the forecast period.

Our regional analysis states that the China captured 24.0% market share in 2022. It was assessed at US$ 946.84 million in 2022 and is likely to hit US$ 1,348.90 million by 2028, exhibiting a CAGR of 4.5% during the forecast period.

Key players dominating the Asia Pacific colorectal cancer market are Abbott, Amgen Inc., Bruker Corporation, Clinical Genomics Technologies Pty Ltd., EDP Biotech Corporation, Epigenomics AG, F. Hoffmann-La Roche AG, Quest Diagnostics, and VolitionRx Limited among others.

Few latest developments among key market players are as follows:

In April 2022, Bruker announced the launch of innovative 7 Tesla and 9.4 Tesla conduction-cooled Maxwell magnets for its market-leading preclinical magnetic resonance imaging (MRI) systems portfolio. Following the success of its BioSpec Maxwell 3 Tesla model, the new range of Maxwell 7 Tesla and 9.4 Tesla magnets eliminates the need for liquid Helium or Nitrogen refills, while offering high-field sensitivity and resolution for advanced preclinical MRI and PET/MR research.

In May 2022, Bruker launches a novel MALDI HiPLEX-IHC tissue imaging solution for timsTOF fleX using AmberGen's HiPLEX-IHC peptide code antibody probes in combination with unbiased lipidomics, glycomics and metabolomics tissue imaging. Improved product efficacy and new development will improve company's product portfolio.

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1   APAC Colorectal Cancer Market – By Modality

1.3.2   APAC Colorectal Cancer Market – By End User

1.3.3   APAC Colorectal Cancer Market – By Country

2. APAC Colorectal Cancer Market – Key Takeaways

3.   Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. APAC Colorectal Cancer– Market Landscape

4.1 Overview

4.2 APAC PEST Analysis

4.3 Expert Opinion

5. APAC Colorectal Cancer Market – Key Market Dynamics

5.1 Market Drivers

5.1.1   Increasing Prevalence of Colorectal Cancer

5.1.2   New Product Launches

5.1.3   Benefits Offered by Generic Drugs

5.2 Market Restraints

5.2.1   Pricing Pressure on Drug Manufacturers

5.3 Market Opportunities

5.3.1   Growing Pharmaceutical Industry in Emerging Economies

5.4 Future Trends

5.4.1   Inclination Toward Personalized Medicine

5.5 Impact Analysis

6. APAC Colorectal Cancer Market– APAC Analysis

6.1 APAC Colorectal Cancer Market Revenue Forecast and Analysis

6.1.1   Overview

7. APAC Colorectal Cancer Market Analysis – By Modality

7.1 Overview

7.2 APAC Colorectal Cancer Market Revenue Share, By Modality 2022 & 2028 (%)

7.3 Diagnosis Type

7.3.1   Overview

7.3.2   Diagnosis Type: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

7.3.3   Immunohistochemistry

7.3.3.1   Overview

7.3.3.2   Immunohistochemistry: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

7.3.4   Stool Test

7.3.4.1   Overview

7.3.4.2   Stool Test: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

7.3.5   Flexible Sigmoidoscopy

7.3.5.1   Overview

7.3.5.2   Flexible Sigmoidoscopy: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

7.3.6   Colonoscopy

7.3.6.1   Overview

7.3.6.2   Colonoscopy: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

7.3.7   CEA Test

7.3.7.1   Overview

7.3.7.2   CEA Test: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

7.3.8   Other Test

7.3.8.1   Overview

7.3.8.2   Other Test: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

7.4 Therapy Type

7.4.1   Overview

7.4.2   APAC Therapy Type: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

7.4.3   Chemotherapy

7.4.3.1   Overview

7.4.3.2   Chemotherapy: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

7.4.3.3   Alkylating Agent

7.4.3.3.1   Overview

7.4.3.3.2   Alkylating Agent: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

7.4.3.4   Antimetabolites

7.4.3.4.1   Antimetabolites: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

7.4.3.5   Others

7.4.3.5.1   Others: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

7.4.4   Immunotherapy

7.4.4.1   Overview

7.4.4.2   Immunotherapy: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

7.4.4.3   Panitumumab

7.4.4.3.1   Overview

7.4.4.3.2   Panitumumab: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

7.4.4.4   Cetuximab

7.4.4.4.1   Overview

7.4.4.4.2   Cetuximab: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

7.4.4.5   Bevacizumab

7.4.4.5.1   Overview

7.4.4.5.2   Bevacizumab: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

7.4.4.6   Others

7.4.4.6.1   Overview

7.4.4.6.2   Others: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

7.4.5   Chemoprotectant

7.4.5.1   Overview

7.4.5.2   Chemoprotectant: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

7.4.6   Others

7.4.6.1   Overview

7.4.6.2   Others: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

7.5 Imaging Type

7.5.1   Overview

7.5.2   APAC Imaging Type: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

7.5.3   Computed Tomography (CT)

7.5.3.1   Overview

7.5.3.2   Computed Tomography (CT) : Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

7.5.4   Magnetic Resonance Imaging (MRI)

7.5.4.1   Overview

7.5.4.2   Magnetic Resonance Imaging (MRI): Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

7.5.5   Others

7.5.5.1   Overview

7.5.5.2   Others: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

8. APAC Colorectal Cancer Market Revenue and Forecast To 2028 – By End User

8.1 Overview

8.2 APAC Colorectal Cancer Market Revenue Share, By End User 2022 & 2028 (%)

8.3 Hospitals

8.3.1   Overview

8.3.2   Hospitals: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Diagnostic and Research Laboratories

8.4.1   Overview

8.4.2   Diagnostic and Research Laboratories: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

9. APAC Colorectal Cancer Market Revenue and Forecast to 2028 – Country Analysis

9.1 Overview

9.1.1   APAC Colorectal Cancer Market Revenue and Forecasts to 2028, By Country (%)

9.1.1.1   China Colorectal Cancer Market Revenue And Forecasts To 2028 (US$ Million)

9.1.1.1.1   China Colorectal Cancer Market Revenue and Forecasts To 2028 (US$ Million)

9.1.1.1.2   China: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)

9.1.1.1.2.1 China: Colorectal Cancer Market, by Diagnosis Type – 2019–2028 (US$ Million)

9.1.1.1.2.2 China: Colorectal Cancer Market, by Therapy Type– 2019- 2028 (US$ Million)

9.1.1.1.2.2.1 China: Colorectal Cancer Market, by Chemotherapy– 2019- 2028 (US$ Million)

9.1.1.1.2.2.2 China: Colorectal Cancer Market, by Immunotherapy– 2019- 2028 (US$ Million)

9.1.1.1.2.3 China: Colorectal Cancer Market, by Imaging Type– 2019- 2028 (US$ Million)

9.1.1.1.3   China: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)

9.1.1.2   Japan Colorectal Cancer Market Revenue and Forecasts To 2028 (US$ Million)

9.1.1.2.1   Japan Colorectal Cancer Market Revenue and Forecasts To 2028 (US$ Million)

9.1.1.2.2   Japan: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)

9.1.1.2.2.1 Japan: Colorectal Cancer Market, by Diagnosis Type – 2019–2028 (US$ Million)

9.1.1.2.2.2 Japan: Colorectal Cancer Market, by Therapy Type– 2019- 2028 (US$ Million)

9.1.1.2.2.2.1 Japan: Colorectal Cancer Market, by Chemotherapy– 2019- 2028 (US$ Million)

9.1.1.2.2.2.2 Japan: Colorectal Cancer Market, by Immunotherapy– 2019- 2028 (US$ Million)

9.1.1.2.2.3 Japan: Colorectal Cancer Market, by Imaging Type– 2019- 2028 (US$ Million)

9.1.1.2.3   Japan : Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)

9.1.1.3   India Colorectal Cancer Market Revenue and Forecasts To 2028 (US$ Million)

9.1.1.3.1   India Colorectal Cancer Market Revenue and Forecasts To 2028 (US$ Million)

9.1.1.3.2   India: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)

9.1.1.3.2.1 India: Colorectal Cancer Market, by Diagnosis Type – 2019–2028 (US$ Million)

9.1.1.3.2.2 India: Colorectal Cancer Market, by Therapy Type– 2019- 2028 (US$ Million)

9.1.1.3.2.2.1 India: Colorectal Cancer Market, by Chemotherapy– 2019- 2028 (US$ Million)

9.1.1.3.2.2.2 India: Colorectal Cancer Market, by Immunotherapy– 2019- 2028 (US$ Million)

9.1.1.3.2.3 India: Colorectal Cancer Market, by Imaging Type– 2019- 2028 (US$ Million)

9.1.1.3.3   India : Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)

9.1.1.4   South Korea Colorectal Cancer Market Revenue And Forecasts To 2028 (US$ Million)

9.1.1.4.1   South Korea Colorectal Cancer Market Revenue and Forecasts To 2028 (US$ Million)

9.1.1.4.2   South Korea: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)

9.1.1.4.2.1 South Korea: Colorectal Cancer Market, by Diagnosis Type – 2019–2028 (US$ Million)

9.1.1.4.2.2 South Korea: Colorectal Cancer Market, by Therapy Type– 2019- 2028 (US$ Million)

9.1.1.4.2.2.1 South Korea: Colorectal Cancer Market, by Chemotherapy– 2019- 2028 (US$ Million)

9.1.1.4.2.2.2 South Korea: Colorectal Cancer Market, by Immunotherapy– 2019- 2028 (US$ Million)

9.1.1.4.2.3 South Korea: Colorectal Cancer Market, by Imaging Type– 2019- 2028 (US$ Million)

9.1.1.4.3   South Korea : Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)

9.1.1.5   Australia Colorectal Cancer Market Revenue and Forecasts To 2028 (US$ Million)

9.1.1.5.1   Australia Colorectal Cancer Market Revenue and Forecasts To 2028 (US$ Million)

9.1.1.5.2   Australia: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)

9.1.1.5.2.1 Australia: Colorectal Cancer Market, by Diagnosis Type – 2019–2028 (US$ Million)

9.1.1.5.2.2 Australia: Colorectal Cancer Market, by Therapy Type– 2019- 2028 (US$ Million)

9.1.1.5.2.2.1 Australia: Colorectal Cancer Market, by Chemotherapy– 2019- 2028 (US$ Million)

9.1.1.5.2.2.2 Australia: Colorectal Cancer Market, by Immunotherapy– 2019- 2028 (US$ Million)

9.1.1.5.2.3 Australia: Colorectal Cancer Market, by Imaging Type– 2019- 2028 (US$ Million)

9.1.1.5.3   Australia : Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)

9.1.1.6   Rest of APAC: Colorectal Cancer Market Revenue and Forecast to 2028 (US$ Million)

9.1.1.6.1   Overview

9.1.1.6.2   Rest of APAC: Colorectal Cancer Market Revenue and Forecasts to 2028 (US$ Million)

9.1.1.6.3   Rest of APAC:: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)

9.1.1.6.3.1 Rest of APAC: Colorectal Cancer Market, by Diagnosis Type – 2019–2028 (US$ Million)

9.1.1.6.3.2 Rest of APAC: Colorectal Cancer Market, by Therapy Type– 2019- 2028 (US$ Million)

9.1.1.6.3.2.1 Rest of APAC: Colorectal Cancer Market, by Chemotherapy– 2019- 2028 (US$ Million)

9.1.1.6.3.2.2 Rest of APAC: Colorectal Cancer Market, by Immunotherapy– 2019- 2028 (US$ Million)

9.1.1.6.3.3 Rest of APAC: Colorectal Cancer Market, by Imaging Type– 2019- 2028 (US$ Million)

9.1.1.6.4   Rest of APAC: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)

10.   Colorectal Cancer Market – Industry Landscape

10.1   Overview

10.2   Growth Strategies In The Colorectal Cancer Market, 2022-2028

10.3   Organic Developments

10.3.1 Overview

10.3.2 Organic Growth Strategies In The Colorectal Cancer Market, 2022-2028

10.4   Inorganic Developments

10.4.1 Overview

10.4.2 Inorganic Growth Strategies In The Colorectal Cancer Market, 2022-2028

11.   Company Profiles

11.1   Epigenomics AG

11.1.1 Key Facts

11.1.2 Business Description

11.1.3 Products and Services

11.1.4 Financial Overview

11.1.5 SWOT Analysis

11.1.6 Key Developments

11.2   Clinical Genomics Technologies Pty. Ltd.

11.2.1 Key Facts

11.2.2 Business Description

11.2.3 Products and Services

11.2.4 Financial Overview

11.2.5 SWOT Analysis

11.2.6 Key Developments

11.3   Abbott

11.3.1 Key Facts

11.3.2 Business Description

11.3.3 Products and Services

11.3.4 Financial Overview

11.3.5 SWOT Analysis

11.3.6 Key Developments

11.4   Amgen Inc.

11.4.1 Key Facts

11.4.2 Business Description

11.4.3 Products and Services

11.4.4 Financial Overview

11.4.5 SWOT Analysis

11.4.6 Key Developments

11.5   F. HOFFMANN-LA ROCHE LTD.

11.5.1 Key Facts

11.5.2 Business Description

11.5.3 Products and Services

11.5.4 Financial Overview

11.5.5 SWOT Analysis

11.5.6 Key Developments

11.6   Bruker Corporation

11.6.1 Key Facts

11.6.2 Business Description

11.6.3 Products and Services

11.6.4 Financial Overview

11.6.5 SWOT Analysis

11.6.6 Key Developments

11.7   Quest Diagnostics Incorporated

11.7.1 Key Facts

11.7.2 Business Description

11.7.3 Products and Services

11.7.4 Financial Overview

11.7.5 SWOT Analysis

11.7.6 Key Developments

11.8   EDP Biotech Corporation

11.8.1 Key Facts

11.8.2 Business Description

11.8.3 Products and Services

11.8.4 Financial Overview

11.8.5 SWOT Analysis

11.8.6 Key Developments

11.9   Volitionrx Limited

11.9.1 Key Facts

11.9.2 Business Description

11.9.3 Products and Services

11.9.4 Financial Overview

11.9.5 SWOT Analysis

11.9.6 Key Developments

12.   Appendix

12.1   About The Insight Partners

12.2   Glossary of Terms

LIST OF TABLES.

Table 1. China Colorectal Cancer Market, by Modality – Revenue and Forecast to 2028 (US$ Million)

Table 2. China Colorectal Cancer Market, by Diagnosis Type – Revenue and Forecast to 2028 (US$ Million)

Table 3. China Colorectal Cancer Market, by Therapy Type – Revenue and Forecast to 2028 (US$ Million)

Table 4. China Colorectal Cancer Market, by Chemotherapy – Revenue and Forecast to 2028 (US$ Million)

Table 5. China Colorectal Cancer Market, by Immunotherapy – Revenue and Forecast to 2028 (US$ Million)

Table 6. China Colorectal Cancer Market, by Imaging Type – Revenue and Forecast to 2028 (US$ Million)

Table 7. China: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)

Table 8. Japan Colorectal Cancer Market, by Modality – Revenue and Forecast to 2028 (US$ Million)

Table 9. Japan Colorectal Cancer Market, by Diagnosis Type – Revenue and Forecast to 2028 (US$ Million)

Table 10.   Japan Colorectal Cancer Market, by Therapy Type – Revenue and Forecast to 2028 (US$ Million)

Table 11.   Japan Colorectal Cancer Market, by Chemotherapy – Revenue and Forecast to 2028 (US$ Million)

Table 12.   Japan Colorectal Cancer Market, by Immunotherapy – Revenue and Forecast to 2028 (US$ Million)

Table 13.   Japan Colorectal Cancer Market, by Imaging Type – Revenue and Forecast to 2028 (US$ Million)

Table 14.   Japan: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)

Table 15.   India Colorectal Cancer Market, by Modality – Revenue and Forecast to 2028 (US$ Million)

Table 16.   India Colorectal Cancer Market, by Diagnosis Type – Revenue and Forecast to 2028 (US$ Million)

Table 17.   India Colorectal Cancer Market, by Therapy Type – Revenue and Forecast to 2028 (US$ Million)

Table 18.   India Colorectal Cancer Market, by Chemotherapy – Revenue and Forecast to 2028 (US$ Million)

Table 19.   India Colorectal Cancer Market, by Immunotherapy – Revenue and Forecast to 2028 (US$ Million)

Table 20.   India Colorectal Cancer Market, by Imaging Type – Revenue and Forecast to 2028 (US$ Million)

Table 21.   India: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)

Table 22.   South Korea Colorectal Cancer Market, by Modality – Revenue and Forecast to 2028 (US$ Million)

Table 23.   South Korea Colorectal Cancer Market, by Diagnosis Type – Revenue and Forecast to 2028 (US$ Million)

Table 24.   South Korea Colorectal Cancer Market, by Therapy Type – Revenue and Forecast to 2028 (US$ Million)

Table 25.   South Korea Colorectal Cancer Market, by Chemotherapy – Revenue and Forecast to 2028 (US$ Million)

Table 26.   South Korea Colorectal Cancer Market, by Immunotherapy – Revenue and Forecast to 2028 (US$ Million)

Table 27.   South Korea Colorectal Cancer Market, by Imaging Type – Revenue and Forecast to 2028 (US$ Million)

Table 28.   South Korea: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)

Table 29.   Australia Colorectal Cancer Market, by Modality – Revenue and Forecast to 2028 (US$ Million)

Table 30.   Australia Colorectal Cancer Market, by Diagnosis Type – Revenue and Forecast to 2028 (US$ Million)

Table 31.   Australia Colorectal Cancer Market, by Therapy Type – Revenue and Forecast to 2028 (US$ Million)

Table 32.   Australia Colorectal Cancer Market, by Chemotherapy – Revenue and Forecast to 2028 (US$ Million)

Table 33.   Australia Colorectal Cancer Market, by Immunotherapy – Revenue and Forecast to 2028 (US$ Million)

Table 34.   Australia Colorectal Cancer Market, by Imaging Type – Revenue and Forecast to 2028 (US$ Million)

Table 35.   Australia: Colorectal Cancer Market Revenue and Forecast to 2028, By End Users (US$ Million)

Table 36.   Rest of APAC: Colorectal Cancer Market Revenue and Forecasts To 2028, By Modality (US$ Million)

Table 37.   Rest of APAC: Colorectal Cancer Market, by Diagnosis Type – Revenue and Forecast to 2028 (US$ Million)

Table 38.   Rest of APAC: Therapy Type Market Revenue and Forecasts To 2028, By Type (US$ Million)

Table 39.   Rest of APAC: Colorectal Cancer Market, by Chemotherapy – Revenue and Forecast to 2028 (US$ Million)

Table 40.   Rest of APAC: Colorectal Cancer Market, byImmunotherapy – Revenue and Forecast to 2028 (US$ Million)

Table 41.   Rest of APAC: Colorectal Cancer Market, by Imaging Type – Revenue and Forecast to 2028 (US$ Million)

Table 42.   Rest of APAC: Colorectal Cancer Market Revenue and Forecasts To 2028, By End User (US$ Million)

Table 43.   Recent Organic Growth Strategies In The Colorectal Cancer Market

Table 44.   Recent Inorganic Growth Strategies In The Colorectal Cancer Market

Table 45.   Glossary of Terms, APAC Colorectal Cancer Market

LIST OF FIGURES.

Figure 1. APAC Colorectal Cancer Market Segmentation

Figure 2. APAC Colorectal Cancer Segmentation, By Country

Figure 3. APAC Colorectal Cancer Market Overview

Figure 4. Diagnosis Type Segment Held Largest Share Of Modality Segment In APAC Colorectal Cancer Market

Figure 5. China is Expected To Show Remarkable Growth During The Forecast Period

Figure 6. APAC Colorectal Cancer Market – PEST Analysis

Figure 7. Comparison of Branded Drugs and Generic Drugs

Figure 8. APAC Colorectal Cancer Market Impact Analysis of Drivers And Restraints

Figure 9. APAC Colorectal Cancer Market – Revenue Forecasts And Analysis – 2020- 2028

Figure 10.   APAC Colorectal Cancer Market Revenue Share, by Modality 2022 & 2028 (%)

Figure 11.   APAC Diagnosis Type: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12.   APAC Immunohistochemistry: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13.   APAC Stool Test: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14.   APAC Flexible Sigmoidoscopy: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15.   APAC Colonoscopy: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16.   APAC CEA Test: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17.   APAC Other Test: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18.   APAC Therapy Type: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19.   APAC Chemotherapy: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20.   APAC Alkylating Agent: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21.   APAC Antimetabolites: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22.   APAC Others: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23.   APAC Immunotherapy: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24.   APAC Panitumumab: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25.   APAC Cetuximab: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26.   APAC Bevacizumab: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27.   APAC Others: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28.   APAC Chemoprotectant: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29.   APAC Others: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30.   APAC Imaging Type: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

Figure 31.   Computed Tomography (CT): Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

Figure 32.   APAC Magnetic Resonance Imaging (MRI): Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

Figure 33.   APAC Others: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

Figure 34.   APAC Colorectal Cancer Market Revenue Share, by End User 2022 & 2028 (%)

Figure 35.   APAC Hospitals: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

Figure 36.   APAC Diagnostic and Research Laboratories: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

Figure 37.   APAC: Colorectal Cancer Market Revenue Overview, By Key Country – Revenue (2022) (US$ Million)

Figure 38.   APAC Colorectal Cancer Market Revenue and Forecasts to 2028, By Country (%)

Figure 39.   China Colorectal Cancer Market Revenue and Forecasts To 2028 (US$ Million)

Figure 40.   Japan Colorectal Cancer Market Revenue and Forecasts To 2028 (US$ Million)

Figure 41.   India Colorectal Cancer Market Revenue And Forecasts To 2028 (US$ Million)

Figure 42.   South Korea Colorectal Cancer Market Revenue and Forecasts to 2028 (US$ Million)

Figure 43.   Australia Colorectal Cancer Market Revenue And Forecasts To 2028 (US$ Million)

Figure 44.   Rest of APAC: Colorectal Cancer Market Revenue and Forecasts to 2028 (US$ Million)

Figure 45.   Growth Strategies In The Colorectal Cancer Market, 2022-2028

The List of Companies - Asia-Pacific Colorectal Cancer Market

● Abbott

● Amgen Inc.

● Bruker Corporation

● Clinical Genomics Technologies Pty Ltd.

● EDP Biotech Corporation

● Epigenomics AG

● F. Hoffmann-La Roche AG

● Quest Diagnostics  

● VolitionRx Limited

● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific colorectal cancer market

● Highlights key business priorities in order to assist companies to realign their business strategies

● The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific colorectal cancer market, thereby allowing players across the value chain to develop effective long-term strategies

● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets

● Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the colorectal cancer market, as well as those hindering it

● Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution

TOP